BELMONT PARK, N.Y. — The New York Islanders today announced a multi-year agreement with Vanda Pharmaceuticals, a global biopharmaceutical company, naming them the team’s exclusive jersey patch partner. The deal marks a milestone for the league, making Vanda the NHL’s first pharmaceutical jersey patch partner.
The Vanda logo will be prominently featured on both the Islanders’ home and away jerseys, debuting October 9 against the Pittsburgh Penguins and continuing with the team’s home opener at UBS Arena on October 11 against the Washington Capitals.
Beyond the visibility on the ice, Vanda branding will appear across Islanders and UBS Arena signage and on the team’s social media throughout the season. The partnership also includes fan-centric initiatives, such as an annual tentpole sweepstakes, content collaborations, and a community program developed jointly with the Islanders, which culminates in a ceremonial puck drop each season at UBS Arena.
“Vanda is a company dedicated to innovation and community, values that resonate deeply with the Islanders and our fan base,” said Dan Griffis, president of global partnerships at Oak View Group, which oversees the Islanders’ corporate partnerships. “We believe this unique collaboration will not only provide significant visibility for Vanda but will also create new, meaningful experiences for our fans both on Long Island and globally.”
To celebrate the new partnership, the Islanders and Vanda will launch a fan-focused sweepstakes, allowing Islanders fans to win a brand-new jersey featuring the Vanda patch to kick off the new season and partnership.
“Vanda is proud in partnering with the New York Islanders, a historic organization, making Vanda the first pharmaceutical jersey patch partner in the NHL,” said Dr. Mihael H. Polymeropoulos, CEO, president and chairman of the board of Vanda Pharmaceuticals. “Vanda’s commitment to health, happiness and excellence is closely aligned with that of the New York Islanders organization and we look forward to an exciting season ahead.”
“We are thrilled to welcome Vanda Pharmaceuticals to the Islanders family as our exclusive jersey patch partner,” said Adam Cross, senior vice president of corporate partnerships for the Islanders. “This is a landmark deal for our organization and the NHL. We look forward to a successful partnership that elevates both of our brands and allows us to further engage with the most passionate fans in the league.”
Vanda Pharmaceuticals is a leading global biopharmaceutical company focused on developing and commercializing innovative therapies to address high unmet medical needs and improve the lives of patients. The company’s mission is centered on advancing scientific knowledge that promotes health and well-being.
The New York Islanders, winners of four Stanley Cup championships and a record nineteen consecutive playoff series victories, play in the NHL’s Eastern Conference. Their state-of-the-art home, UBS Arena, offers world-class hospitality, great sightlines, and an intimate atmosphere for fans. Through the Islanders Children’s Foundation, the organization supports young people in need through fundraising efforts involving players, management, and community partners.
